Croma-Pharma has rolled out electronic Instructions for Use (eIFUs) across its saypha® portfolio. Where allowed by regulation, the company will provide electronic Instructions for Use. These versions may be used in place of printed Instructions for Use in applicable markets. The move will assist healthcare professionals to access key product information digitally. It simultaneously decreases the need for printed documentation.
Healthcare professionals can access the latest approved Instructions for Use through a QR code. The QR code appears directly on the saypha® folding box. After scanning the code, users can access the eIFU platform. The platform provides direct access to the latest approved Instructions for Use. Therefore, healthcare professionals can reach current product information through a convenient digital channel. The approach also supports Croma-Pharma’s broader focus on practical digital healthcare solutions.
The implementation is applicable to the saypha® portfolio in markets where the relevant regulatory approval is available. That way the company can support digital access and stay in line with changing regulatory requirements. The introduction also reflects the evolution of expectations on information about medical products. Digital access can help health care professionals find approved information rather than relying on print.
“Innovation extends beyond product development. It also includes how we provide healthcare professionals with access to essential product information,” said Andreas Prinz, Chief Executive Officer of Croma-Pharma. “The introduction of electronic Instructions for Use across the saypha® portfolio reflects our focus on practical digital solutions that support healthcare professionals and align with evolving regulatory requirements.”
eIFU Supports Digital Access and Sustainability
Environmental benefits of the transition were also highlighted by Croma-Pharma. The company said the project is expected to reduce paper use by the first year. Based on the expected implementation volumes, the paper consumption could be reduced by about 7.7 tons. This figure can be compared to the estimated consumption from printed Instructions for Use.
Further, it is expected that greenhouse gas emissions will be reduced by approximately 10 tons CO₂e. The estimates are derived from projected volumes of implementation and internal calculations. These calculations were based on the data from Ecoinvent database by Croma-Pharma. Thus, the projected figures are based on the company’s planned rollout of electronic Instructions for Use in year 1.
The project links digital product information with actions to reduce environmental impact. Meanwhile, healthcare professionals have a direct line to approved product documentation.
The statement draws attention to the role of digital solutions, not only in product development. It also links eIFU adoption to healthcare professional support and regulatory developments. Moreover, reducing print can help to meet sustainability goals across healthcare operations. The transition therefore solves both digital accessibility and environmental concerns.
saypha® Portfolio grows to include digital documentation
The launch of eIFU is one part of Croma-Pharma’s continuous efforts to further digital access. The company is also attempting to lessen the environmental impact of printed documentation. Electronic Instructions for Use give a direct digital route to healthcare professionals. The packaging features a QR code that gives users access to the latest approved information.
Thus the approach can facilitate the access to product documentation in applicable markets. There is no need to distribute and maintain printed copies. The first year’s projections also serve as a potential environmental impact of the initiative. Croma-Pharma expects a reduction in paper consumption of about 7.7 tons.
At the same time the company expects to reduce CO₂e by around 10 tons. These projections are subject to the implementation volumes and the market roll-out in question. The initiative also reflects the growing use of digital health tools. Healthcare firms keep looking for ways to make information more accessible and to increase operational efficiency.
For Croma-Pharma, the saypha® portfolio is a platform for electronic Instructions for Use. This allows the company to pair digital access with sustainability. Overall, the rollout strengthens Croma-Pharma’s digital delivery of product information. It also allows healthcare professionals to access the current approved documentation.
At the same time, there is less printed material, which also means less consumption of resources. Hence, the initiative links digital transformation with environmental responsibility in the respective markets.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
